Form D/A — Cresilon, Inc.
0001728054-26-000002 · filed Jun 26, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06c
- Reported offering amount
- $29,000,000
- Reported amount sold
- $28,999,199
- Minimum investment
- $10,000
- Investors
- 217
- Sales commission
- $3,429,896
- Finders' fees
- $0
Issuer
- Name
- Cresilon, Inc.
- CIK
- 1728054
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 122 18TH STREET
BROOKLYN, NY 11215 - Phone
- (347) 435-2226
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Joseph Landolina · Executive OfficerBrooklyn, NY Find on LinkedIn ↗
-
Isaac Miller · DirectorBrooklyn, NY Find on LinkedIn ↗
-
Scott Levine · Executive OfficerBrooklyn, NY Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗